Universe Pharmaceuticals (UPC) Cash Flow: Operating & Free Cash Flow

Universe Pharmaceuticals Cash Flow Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Cash flow statement showing operating, investing, and financing activities for Universe Pharmaceuticals INC (UPC) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period ending	Sep 2025	Sep 2024	Sep 2023	Sep 2022	Sep 2021	Sep 2020	Sep 2019	Sep 2018
Operating Activities
Net Income	-3.67	-8.73	-6.58	-7.91	11.32	7.56	7.55	7.60
Depreciation & Amortization	0.52	0.49	0.51	0.53	0.45	0.41	0.42	0.45
Deferred Income Tax	0.00	0.61	1.57	-0.54	-0.67	-0.01	-0.04	0.02
Change in Working Capital	-2.27	-2.06	5.67	6.60	-12.69	-1.87	5.16	-3.53
Change in Accounts Receivable	3.13	-1.71	4.72	-2.56	-3.87	-4.11	0.67	-2.82
Change in Inventory	-0.47	1.64	-1.18	0.02	-0.45	0.89	5.59	-0.33
Change in Accounts Payable	-3.13	0.14	2.00	-2.82	2.46	0.64	-0.92	0.27
Change in Other Working Capital	-1.42	-2.66	0.27	9.64	-10.56	0.71	-0.17	-0.65
Other Operating Activities	0.37	0.79	-0.05	-0.53	-1.14	0.02	0.11	-0.09
Net Cash from Operating Activities	-5.05	-9.51	1.12	-1.30	-2.06	6.12	13.20	4.46
Investing Activities
Capital Expenditures	-0.27	-0.25	-0.04	-0.09	-13.53	-0.05	-0.09	-0.15
Acquisitions	0.00	0.00	0.00	-3.81	26.62	0.00	0.00	0.00
Purchases of Investments	0.00	0.00	0.00	0.00	-15.33	0.00	0.00	0.00
Sales/Maturities of Investments	-0.08	-0.12	0.00	0.00	1.80	0.00	0.00	0.00
Other Investing Activities	-0.08	-0.12	0.00	0.00	-26.62	0.00	0.00	0.00
Net Cash from Investing Activities	-0.34	-0.36	-0.04	-3.91	-27.06	-0.05	-0.09	-0.15
Financing Activities
Debt Repayment	-15.54	-8.36	-10.60	-4.27	-2.76	0.91	0.00	-1.85
Common Stock Issued	15.00	25.00	0.00	0.00	28.75	0.00	0.00	0.00
Dividends Paid	0.00	0.00	0.00	0.00	0.00	0.00	-16.01	-3.06
Other Financing Activities	0.00	0.00	-3.09	3.32	-2.79	-0.44	0.00	0.00
Net Cash from Financing Activities	9.73	33.95	-1.39	3.32	26.58	0.47	-16.00	-4.91
Summary
Effect of Forex Changes on Cash	-237.67	126.09	-0.11	-0.47	0.55	0.35	-0.13	-0.19
Net Change in Cash	4.09	24.21	-0.43	-2.37	-1.98	6.88	-3.01	-0.79
Cash at Beginning of Period	29.50	5.29	5.71	8.08	10.06	3.18	6.19	6.98
Cash at End of Period	33.59	29.50	5.29	5.71	8.08	10.06	3.18	6.19
Free Cash Flow	-5.32	-9.75	1.07	-1.40	-15.59	6.06	13.12	4.31
Supplemental Disclosures
Interest Paid	0.29	0.30	0.19	0.20	0.15	-	-	-
Income Taxes Paid	-	-	0.86	2.75	3.27	-	-	-

Source: Company financial statements from annual and quarterly filings. Data as of Mar 31, 2026. Data sources and methodology

Frequently Asked Questions About Universe Pharmaceuticals Cash Flow

What is Universe Pharmaceuticals's free cash flow?

Universe Pharmaceuticals had negative free cash flow of $5.32M in fiscal 2025 (fiscal year ended Sep 30, 2025), operating cash flow of −$5.05M minus $266.77K of capital expenditures.

How much does Universe Pharmaceuticals spend on capital expenditures?

Universe Pharmaceuticals spent $266.77K on capital expenditures in fiscal 2025, compared with $245.80K a year earlier.

Does Universe Pharmaceuticals pay dividends or buy back shares?

Universe Pharmaceuticals's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition